Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron

A MultiRater MultiOrgan Abdominal CT Dataset for Calibration Analysis and Uncertainty Modeling in Segmentation (2026) Riera-Marin M, Kleiß JM, Aubanell A, Antolin A, Moreno-Vedia J, Rodriguez-Comas J, Sikha OK, et al. Journal article Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review (2026) Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, et al. Journal article Translating ctDNA into cutaneous melanoma care: An international expert survey (2026) Geidel G, Fekade N, Raabe K, Smit DJ, Adam L, Heidrich I, Rünger A, et al. Journal article Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database (2026) Käs F, Elhai M, Becker MO, Dobrota R, Mihai C, Sauer G, Tofani L, et al. Journal article Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma (2026) Dummer R, Sandhu S, Miller WH, Butler MO, Taylor MH, Heinzerling L, Blank CU, et al. Journal article Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers (2026) Magno G, Rejeski K, Rappa G, Stock S, Holzem A, Landwehr M, Seib M, et al. Journal article Perihematomal Edema and Functional Outcome After Intracerebral Hemorrhage: A Meta-Analysis of Individual Participant Data (2026) Samarasekera N, Tuck S, Wang X, Anderson CS, Shirazian A, Volbers B, Huttner H, et al. Journal article Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma (2025) Winkelmann M, Raj SS, Jain MD, Iacoboni G, Müller F, Hansmann L, Corona M, et al. Journal article Calibration and Uncertainty for multiRater Volume Assessment in multiorgan Segmentation (CURVAS) challenge results (2025) Riera-Marín M, O.K. S, Rodríguez-Comas J, May M, Pan Z, Zhou X, Liang X, et al. Journal article Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma (2025) Dummer R, Sandhu S, Miller WH, Butler MO, Taylor MH, Heinzerling L, Blank CU, et al. Journal article